PubMed · 909049
Adjuvant polyarthritis. II. Suppression by tilorone.
Abstract
Tilorone (5-35 mg/kg/day) suppressed the development of adjuvant-induced arthritis and the concurrent development of cell-mediated immune response to a secondary immunogen(EL4 cells) in a dose-related manner. Its influence on the development of the humoral immune response tp EL4 cells was found to be dependent on dosage: stimulatory at low doses (7.5 and 11.0 mg/kg/day), but inhibitory at high doses (24.0 and 35.0 mg/kg/day). Single doses of tilorone (30-300 mg/kg), administered at 24 hours or 1 hour before the injection of carrageenan, suppressed the development of acute inflammation in the rat. Evidence is presented that neither the anti-inflammatory effect of tilorone, nor its influence on the immune response could account for its antiarthritic effect. It appears plausible that the compound may act via interferon induction.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Y H Chang. 1977. Adjuvant polyarthritis. II. Suppression by tilorone.. https://pubmed.ncbi.nlm.nih.gov/909049/
Cite the original work for its findings. Save a collection to share your selection of sources.